Market Cap (In SEK)
7 Million
Revenue (In SEK)
155 Thousand
Net Income (In SEK)
-32.51 Million
Avg. Volume
29.61 Thousand
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.203-2.8
- PE
- -
- EPS
- -
- Beta Value
- 0.641
- ISIN
- SE0010468124
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Ole Thastrup VD
- Employee Count
- -
- Website
- https://www.2curex.com
- Ipo Date
- 2017-11-24
- Details
- 2cureX AB (publ) operates as a medtech company in Europe. Its principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment. The company is also conducting various clinical programs for IndiTreat for breast colorectal, ovarian, and pancreatic cancers. 2cureX AB (publ) was incorporated in 2006 and is based in Copenhagen, Denmark.
More Stocks
-
SVASernova Corp.
SVA
-
000793Huawen Media Group
000793
-
0OQ0
-
002510Tianjin Motor Dies Co.,Ltd.
002510
-
2356
-
0704
-
SPODSpod Lithium Corp.
SPOD
-
CKOCFChudenko Corporation
CKOCF